MT-7716
Nociceptin receptor agonist
From Wikipedia, the free encyclopedia
MT-7716 is an experimental opioid drug that could potentially be used in the treatment of alcohol addiction.
| Names | |
|---|---|
| IUPAC name
2-[3-[1-[(1R)-1,2-Dihydroacenaphthylen-1-yl]piperidin-4-yl]-2-oxobenzimidazol-1-yl]-N-methylacetamide | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C27H28N4O2 | |
| Molar mass | 440.547 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Mechanism of action
Unlike most opioids, MT-7716 does not appear to act through delta, kappa and mu opioid receptors, but instead is an agonist of the nociceptin receptor.[1]
